133 related articles for article (PubMed ID: 9259203)
1. Novel mutations of the P gene in type II oculocutaneous albinism (OCA2).
Spritz RA; Lee ST; Fukai K; Brondum-Nielsen K; Chitayat D; Lipson MH; Musarella MA; Rosenmann A; Weleber RG
Hum Mutat; 1997; 10(2):175-7. PubMed ID: 9259203
[No Abstract] [Full Text] [Related]
2. Mutations of the human P gene associated with Type II oculocutaneous albinism (OCA2). Mutations in brief no. 205. Online.
Oetting WS; Gardner JM; Fryer JP; Ching A; Durham-Pierre D; King RA; Brilliant MH
Hum Mutat; 1998; 12(6):434. PubMed ID: 10671067
[TBL] [Abstract][Full Text] [Related]
3. Mutations of the P gene in oculocutaneous albinism, ocular albinism, and Prader-Willi syndrome plus albinism.
Lee ST; Nicholls RD; Bundey S; Laxova R; Musarella M; Spritz RA
N Engl J Med; 1994 Feb; 330(8):529-34. PubMed ID: 8302318
[TBL] [Abstract][Full Text] [Related]
4. Novel mutations of the tyrosinase (TYR) gene in type I oculocutaneous albinism (OCA1).
Spritz RA; Oh J; Fukai K; Holmes SA; Ho L; Chitayat D; France TD; Musarella MA; Orlow SJ; Schnur RE; Weleber RG; Levin AV
Hum Mutat; 1997; 10(2):171-4. PubMed ID: 9259202
[No Abstract] [Full Text] [Related]
5. [Prenatal diagnosis of oculocutaneous albinism type II and discovery of two novel mutations].
Li HY; Wei HY; Zheng H; Meng S; Jiang WY; Chen LM; Duan HL
Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(16):1123-5. PubMed ID: 17672996
[TBL] [Abstract][Full Text] [Related]
6. Functional characterization of two novel splicing mutations in the OCA2 gene associated with oculocutaneous albinism type II.
Rimoldi V; Straniero L; Asselta R; Mauri L; Manfredini E; Penco S; Gesu GP; Del Longo A; Piozzi E; Soldà G; Primignani P
Gene; 2014 Mar; 537(1):79-84. PubMed ID: 24361966
[TBL] [Abstract][Full Text] [Related]
7. Six novel P gene mutations and oculocutaneous albinism type 2 frequency in Japanese albino patients.
Suzuki T; Miyamura Y; Matsunaga J; Shimizu H; Kawachi Y; Ohyama N; Ishikawa O; Ishikawa T; Terao H; Tomita Y
J Invest Dermatol; 2003 May; 120(5):781-3. PubMed ID: 12713581
[TBL] [Abstract][Full Text] [Related]
8. Novel human pathological mutations. Gene symbol: OCA2. Disease: albinism, oculocutaneous II.
Renugadevi K; Sil AK; Perumalsamy V; Sundaresan P
Hum Genet; 2009 Apr; 125(3):340. PubMed ID: 19309806
[No Abstract] [Full Text] [Related]
9. A novel P gene missense mutation in a Japanese patient with oculocutaneous albinism type II (OCA2).
Kato A; Fukai K; Oiso N; Hosomi N; Saitoh S; Wada T; Shimizu H; Ishii M
J Dermatol Sci; 2003 May; 31(3):189-92. PubMed ID: 12727022
[TBL] [Abstract][Full Text] [Related]
10. Birth prevalence and mutation spectrum in danish patients with autosomal recessive albinism.
Grønskov K; Ek J; Sand A; Scheller R; Bygum A; Brixen K; Brondum-Nielsen K; Rosenberg T
Invest Ophthalmol Vis Sci; 2009 Mar; 50(3):1058-64. PubMed ID: 19060277
[TBL] [Abstract][Full Text] [Related]
11. Mutation analysis in a family with oculocutaneous albinism manifesting in the same generation of three branches.
Preising MN; Forster H; Tan H; Lorenz B; de Jong PT; Plomp AS
Mol Vis; 2007 Oct; 13():1851-5. PubMed ID: 17960121
[TBL] [Abstract][Full Text] [Related]
12. Frequent intragenic deletion of the P gene in Tanzanian patients with type II oculocutaneous albinism (OCA2).
Spritz RA; Fukai K; Holmes SA; Luande J
Am J Hum Genet; 1995 Jun; 56(6):1320-3. PubMed ID: 7762554
[TBL] [Abstract][Full Text] [Related]
13. Oculocutaneous albinism (OCA) in Colombia: first molecular screening of the TYR and OCA2 genes in South America.
Urtatiz O; Sanabria D; Lattig MC
J Dermatol Sci; 2014 Dec; 76(3):260-2. PubMed ID: 25455140
[No Abstract] [Full Text] [Related]
14. Investigation of albinism genes in congenital esotropia.
Burdon KP; Wilkinson RM; Barbour JM; Dickinson JL; Stankovich JM; Mackey DA; Sale MM
Mol Vis; 2003 Dec; 9():710-4. PubMed ID: 14685142
[TBL] [Abstract][Full Text] [Related]
15. A gene for the mouse pink-eyed dilution locus and for human type II oculocutaneous albinism.
Rinchik EM; Bultman SJ; Horsthemke B; Lee ST; Strunk KM; Spritz RA; Avidano KM; Jong MT; Nicholls RD
Nature; 1993 Jan; 361(6407):72-6. PubMed ID: 8421497
[TBL] [Abstract][Full Text] [Related]
16. [Prenatal diagnosis of oculocutaneous albinism type IV and discovery of a novel mutation].
Pang T; Lei J; Zheng H; Xu B; Jiang WY; Li HY
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2011 Feb; 28(1):1-5. PubMed ID: 21287499
[TBL] [Abstract][Full Text] [Related]
17. [Oculocutaneous albinism in French overseas territories (Reunion, French Guyana, Martinique) and Mayotte. Study of 21 cases in 16 families].
Aquaron R; Berge-Lefranc JL; Badens C; Roche J; Fite A; Sainte-Marie D; Piquion N; Cartault F
Med Trop (Mars); 2005 Nov; 65(6):584-91. PubMed ID: 16555521
[TBL] [Abstract][Full Text] [Related]
18. Oculocutaneous albinism in an isolated Tonga community in Zimbabwe.
Lund PM; Puri N; Durham-Pierre D; King RA; Brilliant MH
J Med Genet; 1997 Sep; 34(9):733-5. PubMed ID: 9321758
[TBL] [Abstract][Full Text] [Related]
19. Type 2 oculocutaneous albinism (OCA2) in Zimbabwe and Cameroon: distribution of the 2.7-kb deletion allele of the P gene.
Puri N; Durbam-Pierre D; Aquaron R; Lund PM; King RA; Brilliant MH
Hum Genet; 1997 Oct; 100(5-6):651-6. PubMed ID: 9341887
[TBL] [Abstract][Full Text] [Related]
20. [Identification of a novel pathogenic mutation in MATP gene with oculocutaneous albinism type IV from a consanguineous marriage family].
Xu B; Pang T; Yao CQ; Zhang LY; Zheng H; Jiang WY; Li HY
Zhonghua Yi Xue Za Zhi; 2012 Jan; 92(4):254-8. PubMed ID: 22490798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
